Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 020326

Expand all

NEUTREXIN (TRIMETREXATE GLUCURONATE)
EQ 25MG BASE/VIAL
Marketing Status: Discontinued

Active Ingredient: TRIMETREXATE GLUCURONATE
Proprietary Name: NEUTREXIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 25MG BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020326
Product Number: 001
Approval Date: Dec 17, 1993
Applicant Holder Full Name: MEDIMMUNE ONCOLOGY INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

NEUTREXIN (TRIMETREXATE GLUCURONATE)
EQ 200MG BASE/VIAL
Marketing Status: Discontinued

Active Ingredient: TRIMETREXATE GLUCURONATE
Proprietary Name: NEUTREXIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 200MG BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020326
Product Number: 002
Approval Date: Jul 31, 1998
Applicant Holder Full Name: MEDIMMUNE ONCOLOGY INC
Marketing Status:  Discontinued
Patent and Exclusivity Information